Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26
- 9 March 2016
- journal article
- research article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 48 (5) , 2124-2134
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 29 references indexed in Scilit:
- Peptides in Receptor-Mediated Radiotherapy: From Design to the Clinical Application in CancersFrontiers in Oncology, 2013
- Evolution of Bombesin Conjugates for Targeted PET Imaging of TumorsPLOS ONE, 2012
- Bombesin Antagonist–Based Radioligands for Translational Nuclear Imaging of Gastrin-Releasing Peptide Receptor–Positive TumorsJournal of Nuclear Medicine, 2011
- Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7–14)NH2], in a prostate tumor xenografted mouse modelNuclear Medicine and Biology, 2010
- Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for the Molecular Imaging EraChemical Reviews, 2010
- Specific to nonspecific binding in radiopharmaceutical studies: it's not so simple as it seems!Nuclear Medicine and Biology, 2009
- Metal‐Ion‐Dependent Biological Properties of a Chelator‐Derived Somatostatin Analogue for Tumour TargetingChemistry – A European Journal, 2008
- Radiolabeled somatostatin receptor antagonists are preferable to agonists forin vivopeptide receptor targeting of tumorsProceedings of the National Academy of Sciences, 2006
- NMR Studies Reveal Structural Differences between the Gallium and Yttrium Complexes of DOTA-d-Phe-Tyr3-octreotideJournal of Medicinal Chemistry, 2005
- Molecular Basis for Selectivity of High Affinity Peptide Antagonists for the Gastrin-releasing Peptide ReceptorJournal of Biological Chemistry, 2001